Related Experiment Video
Updated: Apr 10, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The
A Velescu1, A Clara2, J Peñafiel3
1Angiology and Vascular Surgery Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Universitat Autònoma de Barcelona, Spain.
Insights
Adding the ankle-brachial index (ABI) to the Framingham-REGICOR risk function significantly improves cardiovascular disease (CVD) prediction. This simple test enhances risk stratification, supporting its use in primary prevention strategies.
Area of Science:
- Cardiology
- Preventive Medicine
- Biomarker Research
Background:
- Cardiovascular risk estimation is crucial for primary prevention but current methods have limited accuracy.
- Novel biomarkers are investigated to enhance prediction of coronary heart disease (CHD) and cardiovascular disease (CVD).
- The ankle-brachial index (ABI) is a potential biomarker for assessing peripheral artery disease and cardiovascular risk.
Purpose of the Study:
- To evaluate if incorporating the ankle-brachial index (ABI) improves the predictive performance of the Framingham-REGICOR risk function.
- To assess ABI's utility in a population with low incidence of cardiovascular disease (CVD).
Main Methods:
- A prospective population-based cohort study followed 5248 individuals (aged 35-74) for a median of 5.9 years.
- Baseline ankle-brachial index (ABI) was measured using a standardized method.
- Improvements in prediction were assessed using discrimination (ΔC-statistics) and reclassification (net reclassification index, NRI).
Main Results:
- A pathological ABI (≤0.9) was significantly associated with increased CHD and CVD risk (HR: 2.08 and 2.24, respectively; p<0.001).
- Inclusion of ABI improved discrimination (ΔC-statistic: 0.007) and reclassification (NRI: 0.029) for CVD events (p<0.001).
- ABI did not significantly improve prediction for coronary heart disease (CHD) events alone.
Conclusions:
- The ankle-brachial index (ABI) enhances the predictive accuracy of the Framingham-REGICOR risk function, particularly for overall CVD events.
- The findings support the value of integrating ABI into cardiovascular risk stratification protocols.
- This simple, non-invasive test aligns with recommendations for improving cardiovascular risk assessment in primary prevention.
Objectives:
Cardiovascular risk estimation is a key element of current primary prevention strategies, despite its limited accuracy. Several biomarkers are being tested to assess their capacity to improve coronary (CHD) and cardiovascular (CVD) prediction. One of these biomarkers is ankle brachial index (ABI). The aim of this study was to assess whether the inclusion of ABI improved the predictive capacity of the Framingham-REGICOR risk function in an area of low CVD incidence.
Methods:
A total of 5248 individuals, aged 35-74 years, from a prospective population-based cohort study were followed up for a median 5.9 years. Baseline ABI was measured using a standardized method. All incident CHD (angina, myocardial infarction, coronary revascularization, CHD death) and CVD (also including fatal and non-fatal stroke) events were recorded. Improvements in discrimination (ΔC-statistics) and reclassification by net reclassification index (NRI) were assessed.
Results:
During follow-up, 111 and 64 subjects presented with a coronary or cerebrovascular event. Pathological ABI (≤0.9) was associated with increased CHD and CVD risk (HR: 2.08 and HR: 2.24, respectively; p-value<0.001). Including ABI in the Framingham-REGICOR function improved both its discrimination and its reclassification capacity for CVD events but not for CHD events; the ΔC-statistic for CVD events was 0.007 (95% Confidence Interval: 0.001; 0.017) and the NRI was 0.029 (95% CI: 0.014-0.045; p-value<0.001).
Conclusion:
Inclusion of the ABI improves the predictive capacity of the Framingham-REGICOR risk function. The study results indicate the potential value of including this simple test in cardiovascular risk stratification and support current guidelines recommendations.
More Related Videos
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
14:52Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Assessment of blood pressure in brachial artery(two-step method)
Pre-Procedural Guidelines for Assessing Blood Pressure
Sites for measuring blood pressure
The Brachial Artery: Primary Site for Blood Pressure Measurement
Assessing Blood pressure in the Leg
Preparation: